The goal of the app is to spread new knowledge in cancer. It is a portal to a massive searchable database of companies involved in new drugs for cancer and new drugs in development. It ranks new drugs in trials with response rates or headline data and provides further summarised analysis. It tracks data produced from the explosive growth in the new immunotherapy industry, where survival rates for major cancers are doubling. Users are analysts, fund managers, companies and anyone with an interest in new cancer drugs. Menus include lung cancer drugs, colorectal cancer, lymphoma and others. Category of agent such as immuno-oncology drugs, stem cell agents, vaccines or biomarker targets are provided in menus with specialised analysis. Other views such as Nordic companies or key summaries and advances in cancer are included. Key updates and press releases in cancer are accessed and interactive features will be provided to collect big data in cancer.